Skip to main content
PATIENT PRESENTATION MARKER 

Report of IBD

What this marker measures

Whether the patient reported a diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis). 

Health categories/Interpretations informed by this marker

‍
Gut environment 
‍
‍● Gut inflammation
‍

Interpreting the result

PRESENT
Questionnaire responses indicate a medical diagnosis of Crohn's disease or ulcerative colitis.
NOT PRESENT
Questionnaire responses do not indicate a medical diagnosis of Crohn's disease or ulcerative colitis.

Tips for patients discussion

"Your questionnaire responses show you've been diagnosed with Crohn's disease or ulcerative colitis. We'll keep this in mind as we look at your other results, and continue to work alongside your specialist." 

© Copyright 2025 Microba Life Sciences
THESE PRODUCTS ARE ONLY AVAILABLE FOR PURCHASE THROUGH A HEALTHCARE PROFESSIONAL.
1. The quantitative faecal occult blood, polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assays (ELISA) used in the Microbiome Explorer range are diagnostic and are approved for clinical use.
2. The faeces pH assay used in the Microbiome Explorer range is for research use only and not to be used as a basis for diagnosis. The metagenomic assays used in the Microbiome Explorer range are to determine the microbiome populations and associated functional pathways in a faecal sample. The application is for research use only and not to be used as a basis for diagnosis. Learn more about the journey we are on to validate this gold-standard technology for clinical diagnosis and application.
3. The Microbiome Explorer range is intended for adults 18 years or older only.

Disclaimer:
The information provided on this site is for the use of qualified healthcare professionals. The information contained on this website is in no way to be taken as prescriptive or to replace the healthcare professional's duty of care and personalised care practices.